13 results
8-K
EX-99.1
PLX
Protalix BioTherapeutics Inc.
26 Dec 23
Protalix BioTherapeutics Issues 2024 Letter to Stockholders
6:56am
to our mission. I also want to thank you, our stockholders, for your continued confidence and trust in our vision. As we navigate the exciting journey
8-K
EX-99.1
PLX
Protalix BioTherapeutics Inc.
10 May 23
Other Events
6:25am
biopharmaceuticals group that develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission
8-K
EX-99.1
PLX
Protalix BioTherapeutics Inc.
5 May 23
Other Events
6:56am
solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly
8-K
EX-99.1
PLX
Protalix BioTherapeutics Inc.
14 Nov 22
Protalix BioTherapeutics Reports Third Quarter 2022 Financial and Business Results
7:03am
dedication to our mission of bringing new medicines to patients with serious diseases. We are grateful to our team members and external partners
8-K
EX-99.2
PLX
Protalix BioTherapeutics Inc.
14 Nov 22
Protalix BioTherapeutics Reports Third Quarter 2022 Financial and Business Results
7:03am
). To
achieve its mission of improving people’s quality of life by acting responsibly towards society and the environment, the Group researches
8-K
EX-99.1
vortelldgz47
16 May 22
Protalix BioTherapeutics Reports First Quarter 2022 Financial and Business Results
7:00am
8-K
EX-99.1
ch8cxzys 35qozp28lbj
4 Apr 22
Other Events
6:59am
8-K
EX-99.1
0tqnlwm
31 Mar 22
Protalix BioTherapeutics Reports Fiscal Year 2021 Financial and Business Results
7:01am
8-K
EX-99.1
u320i3hab3v
24 Feb 22
Other Events
9:19am
8-K
EX-99.1
et3wks8i147ch
15 Nov 21
BioTherapeutics Reports Third Quarter 2021 Financial
7:06am
8-K
EX-99.1
nzv19ik
12 Oct 21
Protalix Biotherapeutics and Chiesi Global Rare Diseases Provide Regulatory Update on PRX-102 for the Treatment of Fabry Disease
6:03am
8-K
EX-99.1
cl4chufalw4
29 Oct 20
Protalix BioTherapeutics Reports Third Quarter 2020 Financial Results and Provides Business Update
7:12am
8-K
EX-99.1
5its4t6sp
4 Jan 11
Protalix BioTherapeutics Announces Presentation of PRX-105 Data at the BARDA Industry Day
12:00am
- Prev
- 1
- Next